Company Overview of Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing two extracts, including Phytofare Catechin Complex, which is derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare Limonoid Glycoside Complex extracted from lemons that are sourced from plantations in South Africa. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. In addition, it intends to use its plantation leases to focus on the farming of whole fruits, vegetables, and live plant material. The company is based in...
1451 North 200 East
Logan, UT 98102
Key Executives for Plandaí Biotechnology, Inc.
Co-Founder, Chairman, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer and Secretary
Total Annual Compensation: $117.5K
Vice President of Sales and Director
Total Annual Compensation: $95.0K
Vice President of Marketing and Director
Total Annual Compensation: $9.0K
Compensation as of Fiscal Year 2014.
Plandaí Biotechnology, Inc. Key Developments
Plandaí Biotechnology, Inc. announced delayed 10-Q filing
May 15 15
On 05/15/2015, Plandaí Biotechnology, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Plandaí Biotechnology, Inc. Announces its Entry into an Exclusive 3 Year Supply Agreement with USN Worldwide
May 11 15
Plandaí Biotechnology, Inc. announced its entry into an exclusive 3 year supply agreement with USN Worldwide. Pursuant to the contract, the Company will initially sell to USN commercial amounts of Phytofare(R) catechin complex for USN'S South African markets. Ultimately, the parties intend to expand USN's purchases globally into other territories in which USN operates. This agreement also allows USN to further control the input costs around production, while enhancing product efficacy by replacing the generic green tea extracts in its extensive stable of innovative and market leading products, with the clinically proven highly bioavailable Phytofare(R) catechin complex. This agreement gives Plandai the opportunity to cement its relationship with a long-term global customer who has a vision for growth and market expansion.
Plandaí Biotechnology, Inc. Announces Change of Independent Certifying Accountants
Apr 28 15
On April 22, 2015, Plandaí Biotechnology, Inc. accepted the resignation of Terry L. Johnson, CPA from his engagement to be the independent certifying accountant for the company. On April 22, 2015, the company's Board of Directors approved the engagement of Danielle M. Adams, CPA of Adams Advisory, LLC, as the company's independent accountant effective immediately to audit the company's financial statements and to perform reviews of interim financial statements.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|